STOCK TITAN

Quantum X Labs names Yakov Baranes sole CEO

Co-Chief Executive Officer Amihay Hadad steps down, and Yakov Baranes becomes sole CEO of Quantum X Labs Inc. effective September 22, 2026.

(High)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Quantum X Labs Inc. (QXL) announced a leadership change in its top executive role. On September 22, 2026, Amihay Hadad notified the board that he is stepping down as the Company’s Co-Chief Executive Officer, effective immediately, and the Company states this decision was not due to any disagreement regarding its operations, policies or practices.

Effective the same day, Yakov Baranes, who has served as Co-Chief Executive Officer since May 2026, was appointed as the Company’s sole Chief Executive Officer, consolidating the CEO role under a single individual.

Positive

  • None.

Negative

  • Co-CEO steps down effective immediately, with Amihay Hadad leaving the Co-Chief Executive Officer role, creating a notable leadership change at the top of Quantum X Labs Inc.

Insights

Analyzing...

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Effective date of Co-CEO resignation September 22, 2026 Date Amihay Hadad stepped down as Co-Chief Executive Officer
Effective date of sole CEO appointment September 22, 2026 Date Yakov Baranes became sole Chief Executive Officer
Trading symbol QXL Common Stock listed on The Nasdaq Capital Market
Par value per share $0.0001 per share Common Stock of Quantum X Labs Inc.
Commission File Number 001-42681 SEC registration reference for Quantum X Labs Inc.
Emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Nasdaq Capital Market market
"Name of each exchange on which registered Common Stock ... The Nasdaq Capital Market"
The Nasdaq Capital Market is a platform where smaller, emerging companies can list their shares for trading by investors. It provides these companies with access to funding and visibility, helping them grow, much like a local marketplace where new vendors can introduce their products to potential customers. For investors, it offers opportunities to discover early-stage companies with growth potential.
Common Stock, par value $0.0001 per share financial
"Title of each class Common Stock, par value $0.0001 per share"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What executive leadership change did QUANTUM X LABS INC. (QXL) disclose?

Quantum X Labs Inc. reported that Amihay Hadad stepped down as Co-Chief Executive Officer, effective September 22, 2026, and that Yakov Baranes, previously Co-CEO, was appointed as the Company’s sole Chief Executive Officer the same day.

When did the CEO transition at QXL take effect?

The CEO transition took effect on September 22, 2026. On that date, Amihay Hadad stepped down as Co-Chief Executive Officer, and Yakov Baranes was appointed as the sole Chief Executive Officer of Quantum X Labs Inc.

Did Amihay Hadad’s departure from QXL involve any disagreement with the company?

No. Quantum X Labs Inc. states that Mr. Hadad’s decision to step down as Co-Chief Executive Officer was not the result of any disagreement relating to the Company’s operations, policies, or practices.

What is Yakov Baranes’s background role at QXL before becoming sole CEO?

Before becoming sole CEO, Yakov Baranes had served as Co-Chief Executive Officer of Quantum X Labs Inc. since May 2026, sharing the role with Amihay Hadad until the September 22, 2026 transition.

On which market is QUANTUM X LABS INC. (QXL) listed and what class of shares trade?

Quantum X Labs Inc.’s Common Stock, par value $0.0001 per share, trades under the symbol QXL on The Nasdaq Capital Market, according to the disclosure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false 0000797542 0000797542 2026-09-22 2026-09-22 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of report (date of earliest event reported): September 22, 2026

 

QUANTUM X LABS INC.

 

(Exact Name of Registrant as Specified in its Charter)

 

Commission File No.: 001-42681

 

Delaware   68-0080601
(State of Incorporation)   (I.R.S. Employer Identification No.)

 

2 Jabotinsky St, Atrium Tower, 18th floor

Ramat Gan, Israel

  5252903
(Address of Registrant’s Office)   (ZIP Code)

 

Registrant’s Telephone Number, including area code: +972 9-774-1505

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.0001 per share   QXL   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On September 22, 2026, Mr. Amihay Hadad notified the Board of Directors of Quantum X Labs Inc. (the “Company”) of his decision to step down from his position as the Company’s Co-Chief Executive Officer, effective immediately.

 

Mr. Hadad’s decision to step down was not the result of any disagreement with the Company relating to the Company’s operations, policies or practices.

 

Effective as of September 22, 2026, Mr. Yakov Baranes, who has served as the Company’s Co-Chief Executive Officer since May 2026, was appointed as the Company’s sole Chief Executive Officer.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Quantum X Labs Inc.  
     
By: /s/ Yakov Baranes  
Name: Yakov Baranes  
Title: Chief Executive Officer  

 

Date: September 22, 2026

 

 

Filing Exhibits & Attachments

3 documents

Keep reading